The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Williams Laura A since 2022.
This trader's CIK number is 1869194.
At the time of last reporting, Williams Laura A was the Chief Patient Officer of Ardelyx, Inc.. (stock ticker symbol ARDX).
Also see all insider trading activities at Ardelyx, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ARDX | 0 | $0 | 97,623 | $580,807 | 50,000 | $49,500 |
| 2024 | ARDX | 0 | $0 | 169,375 | $1,191,185 | 100,000 | $275,000 |
| 2023 | ARDX | 0 | $0 | 60,942 | $223,085 | 0 | $0 |
| 2022 | ARDX | 6,000 | $3,714 | 3,758 | $6,079 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-26 | ARDX | Option Ex | 50,000 | .99 | 49,500 |
| 2025-08-26 | ARDX | Sale | 80,000 | 6.12 | 489,680 |
| 2025-08-21 | ARDX | Sale | 6,261 | 5.93 | 37,140 |
| 2025-05-20 | ARDX | Sale | 6,421 | 4.08 | 26,204 |
| 2025-02-20 | ARDX | Sale | 4,941 | 5.62 | 27,783 |
| 2024-11-20 | ARDX | Sale | 7,366 | 4.79 | 35,319 |
| 2024-08-20 | ARDX | Sale | 7,412 | 5.86 | 43,434 |
| 2024-06-05 | ARDX | Option Ex | 100,000 | 2.75 | 275,000 |
| 2024-06-05 | ARDX | Sale | 145,000 | 7.12 | 1,032,980 |
| 2024-05-21 | ARDX | Sale | 4,794 | 7.81 | 37,445 |
| 2024-02-20 | ARDX | Sale | 4,803 | 8.75 | 42,007 |
| 2023-11-20 | ARDX | Sale | 2,581 | 4.36 | 11,258 |
| 2023-11-15 | ARDX | Sale | 25,000 | 4.00 | 100,000 |
| 2023-08-21 | ARDX | Sale | 2,591 | 3.55 | 9,203 |
| 2023-06-27 | ARDX | Sale | 25,000 | 3.35 | 83,625 |
| 2023-05-23 | ARDX | Sale | 2,583 | 3.65 | 9,435 |
| 2023-02-21 | ARDX | Sale | 3,187 | 3.00 | 9,564 |
| 2022-11-22 | ARDX | Sale | 1,241 | 1.95 | 2,413 |
| 2022-11-22 | ARDX | Sale | 1,241 | 1.95 | 2,413 |
| 2022-08-31 | ARDX | Buy | 3,000 | .62 | 1,857 |
| 2022-08-31 | ARDX | Buy | 3,000 | .62 | 1,857 |
| 2022-08-22 | ARDX | Sale | 1,276 | .98 | 1,253 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Williams Laura A (Chief Patient Officer of Ardelyx, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.